Rationale and design of the CT-STEMI study (Cardiac Computed Tomography for comprehensive risk stratification of
Marco Gatti1, Guglielmo Gallone2, Tommaso D'Angelo3
1Department of Surgical Sciences, Radiology Unit, University of Turin, Via Genova 3, 10126, Turin, Italy.
Insights
Cardiac computed tomography (CCT) shows promise for assessing ST-segment elevation myocardial infarction (STEMI) patients. This study validates CCT as a cost-effective tool for risk stratification and coronary evaluation, potentially improving patient outcomes.
Area of Science:
- Cardiology
- Medical Imaging
- Diagnostic Technology
Background:
- ST-segment elevation myocardial infarction (STEMI) is a leading cause of death and disability, with survivors at high risk for heart failure, ischemia, and arrhythmias.
- Cardiac magnetic resonance (CMR) is effective for risk stratification post-STEMI but faces accessibility and cost limitations.
- Cardiac computed tomography (CCT) is evolving as a comprehensive imaging tool for assessing myocardial function and tissue characteristics.
Purpose of the Study:
- To evaluate CCT's accuracy in myocardial assessment and tissue characterization compared to CMR in STEMI patients.
- To determine the prognostic value of CCT-derived features for adverse outcomes after STEMI.
- To assess CCT's utility in quantifying atherosclerotic burden in STEMI patients.
Main Methods:
- Prospective, multicenter observational study (CT-STEMI) enrolling STEMI patients treated with primary PCI.
- Patients undergo comprehensive CCT and CMR within 10 days of the event, with randomized imaging sequences.
- Longitudinal follow-up for heart failure, arrhythmias, and recurrent ischemic events.
Main Results:
- This section is to be filled upon study completion.
Conclusions:
- CCT may serve as a cost-effective, comprehensive imaging modality for post-STEMI risk stratification and coronary evaluation.
- Successful validation could establish CCT as an efficient, 'one-stop' diagnostic tool.
- This approach has the potential to enhance patient outcomes and optimize healthcare resource utilization.
Background:
ST-segment elevation myocardial infarction (STEMI) remains a major cause of morbidity and mortality, with survivors facing high risk of heart failure, recurrent ischemia, and arrhythmias. Risk stratification traditionally relies on echocardiography, while cardiac magnetic resonance (CMR) is the most effective tool for predicting adverse outcomes. However, its routine use is limited by accessibility, cost, and logistical constraints. Recently, cardiac computed tomography (CCT) has evolved from an angiographic tool to a comprehensive imaging modality capable of assessing wall motion abnormalities and myocadial tissue characteristics.
Objectives:
The CT-STEMI study aims to (1) evaluate the diagnostic accuracy of CCT for myocardial morphofunctional assessment and tissue characterization compared to CMR, (2) determine the prognostic value of CCT-derived features for adverse outcomes, and (3) assess the role of CCT in quantifying atherosclerotic burden in STEMI patients.
Methods:
CT-STEMI (NCT06020209) is a prospective, multicenter observational study enrolling STEMI patients treated with primary PCI within 24 h of symptom onset. Each patient undergoes comprehensive CCT (pre-contrast imaging, full R-R interval angiography, and late iodine enhancement) and CMR within 10 days of the acute event, with imaging sequence randomized. Patients will be followed longitudinally for heart failure, arrhythmic events, and recurrent ischemic complications.
Summary:
This study aims to validate CCT as a cost-effective, comprehensive imaging modality for post-STEMI risk stratification, with the added benefit of coronary artery evaluation. If successful, CCT could serve as an efficient, one-stop diagnostic tool, enhancing patient outcomes while optimizing healthcare resources.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies


